![Domitille de Vienne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Domitille de Vienne
Directeur/Bestuurslid bij DalCor Pharmaceuticals Canada, Inc.
Actieve functies van Domitille de Vienne
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DalCor Pharmaceuticals Canada, Inc.
![]() DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Directeur/Bestuurslid | - | - |
Loopbaan van Domitille de Vienne
Statistieken
Internationaal
Canada | 2 |
Operationeel
Director/Board Member | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
DalCor Pharmaceuticals Canada, Inc.
![]() DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Health Technology |
- Beurs
- Insiders
- Domitille de Vienne
- Ervaring